2018
DOI: 10.1097/md.0000000000010636
|View full text |Cite
|
Sign up to set email alerts
|

Spore powder of Ganoderma lucidum for the treatment of Alzheimer disease

Abstract: Background:This study explored the feasible efficacy and safety of the Spore Powder of Ganoderma Lucidum (SPGL) for treating patients with Alzheimer disease (AD).Methods:Forty-two eligible patients with AD were recruited. These patients were randomly allocated to an intervention group and a control group equally. The patients in the intervention group underwent SPGL, whereas the subjects in the control received placebo. All patients were treated for a total of 6 weeks. The primary outcome was measured by Alzhe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
15
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 23 publications
(17 citation statements)
references
References 25 publications
1
15
0
Order By: Relevance
“…Our results confirm the safety of GL. The minor side effects we found were in accordance with those encountered in previous studies [ 25 ].…”
Section: Discussionsupporting
confidence: 92%
“…Our results confirm the safety of GL. The minor side effects we found were in accordance with those encountered in previous studies [ 25 ].…”
Section: Discussionsupporting
confidence: 92%
“…Beside the well‐documented large‐scale clinical studies on the Ginkgo biloba extract Egb761, 225 only a few randomized, placebo controlled trials have been published 226–233 . The majority of (poly)phenol‐rich plant extracts were tested in open‐label trials 234–237 . Moreover, most studies tested effects of (poly)phenol‐rich extracts over a relative short time on only a small number of participants and the studied plant material was often not well characterized, with some exceptions such as human studies on Egb761R or Cistanche tubulosa glycosides (Memoregain R ) 225,235 .…”
Section: Role Of Biofactors In Neurodegenerative Diseasesmentioning
confidence: 99%
“…G. lucidium (also known as the "mushroom of immortality" or the "longevity mushroom") and its close relative Ganoderma lingzhi (Sheng H. Wu, Y. Cao, and Y. C. Dai), which has been used in traditional Chinese medicine, contains several bioactive compounds for the alleviation of diseases [62]. Because G. lucidium contains numerous bioactive compounds with alleged health benefits without obvious side effects, it has a reputation as an herbal medicine The bioactive compounds and extracts isolated from different parts of G. lucidum include polysaccharides, β-glucans, lectins, amino acids, lignin, mycin, and vitamins, which have potential antioxidant, anti-inflammatory, and neuroprotective effects [62,63]. Ganodermasides A-D (43)(44)(45)(46), the biologically active compounds obtained from different parts of G. lucidum, increase life span and show antiaging properties [64][65][66].…”
Section: Ganoderma Lucidummentioning
confidence: 99%